| Financial Year |
March 31 2023 |
| Monetary Funds |
4,510,052,114.69 |
| Held-for-trading Financial Assets |
25,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
885,902,392.68 |
| Advances to Suppliers |
1,976,462,580.12 |
| Other Receivables |
184,965,329.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,410,519,466.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
14,480,182.55 |
| Other Current Assets |
1,071,146,418.27 |
| Total Current Assets |
13,205,927,960.82 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
126,545,722.44 |
| Long-term Equity Investment |
288,513,468.84 |
| Investment Properties |
-- |
| Fixed Assetes |
8,397,384,088.91 |
| Under-construction Projects |
1,564,575,777.71 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
476,206,842.63 |
| R&D expenses |
92,725,363.71 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
10,554,800.93 |
| Deferred Income Tax Assets |
59,363,277.07 |
| Other Non-Current Assets |
390,868,239.33 |
| Sub-Total of Non-Current Assets |
11,471,187,891.54 |
| Total Assets |
24,677,115,852.36 |
| Short-Term Loans |
4,350,796,130.32 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,808,690,941.36 |
| Accounts Payable |
1,980,975,953.86 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
86,820,252.53 |
| Taxes Payable |
92,519,710.31 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,375,993,483.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,078,236,303.76 |
| Other Current Liabilities |
146,326,555.94 |
| Sub-Total of Current Liabilities |
15,699,737,588.96 |
| Long-term Loans |
538,210,375.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
846,187,401.76 |
| Special Payable |
-- |
| Estimatied Liabilities |
262,307.50 |
| Deferred Income Tax Liabilities |
42,490,961.21 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,514,615,142.52 |
| Total Liabilities |
17,214,352,731.48 |
| Paid-In Capital(Or Share Stock) |
1,870,661,251.00 |
| Capital Surplus |
3,235,550,426.74 |
| Surplus Reserve |
459,249,382.72 |
| LESS:Treasury Stock |
56,413,800.00 |
| Undistributed Profits |
1,827,499,254.83 |
| Minority Stockholder's Interest |
120,365,855.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,342,397,264.97 |
| Owner's Equity（Stockholder's Equity） |
7,462,763,120.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
24,677,115,852.36 |
